Hospital Corporation of China Limited (HOSPITAL CORP, 03869) reported a clean sweep of approvals at its Annual General Meeting held on 18 June 2026 in Beijing. Every item on the eight-resolution agenda—seven ordinary and one special—secured 100.00% of the 97.00 million votes cast, underscoring full shareholder support for the company’s governance slate and capital-management flexibility.
Key takeaways
1. Financial statements adopted • The audited consolidated results for the year ended 31 December 2025 were approved without opposition, signalling shareholder confidence in the company’s reported performance and disclosures.
2. Board continuity assured • All five directors standing for re-election—Executive Director Pan Jianli; Non-Executive Directors Liu Lu and Wang Nan; and Independent Non-Executive Directors Dang Jinxue and Zhou Xiangliang—were returned with unanimous support. • The Board also received authority to determine directors’ remuneration.
3. Auditor reappointed • KPMG was re-appointed as external auditor, with the Board authorised to fix its remuneration, maintaining consistency in the company’s audit oversight.
4. Capital management mandates refreshed • Shareholders renewed a 10% share-repurchase mandate and a 20% general issuance mandate, while also approving the extension mechanism that allows repurchased shares to be added back to the issuance pool. The mandates provide the Board with flexibility equivalent to up to 13.82 million shares for buy-backs and 27.64 million shares for new issues, based on the 138.19 million total issued shares as of the meeting date.
5. Governance framework updated • A special resolution adopting the third amended and restated memorandum and articles of association passed with 100.00% support, exceeding the 75% threshold required for special resolutions.
Additional details
• Voting base: 136.50 million shares were eligible to vote after excluding 1.70 million shares held under the company’s share award scheme, whose trustee abstained as required. • Scrutiny: Computershare Hong Kong Investor Services Limited acted as the scrutineer, and all directors were present. • Leadership: The announcement was authorised by Chairman and Acting CEO Chen Shuai.
Full voting results and procedural notes are available in the company’s official filing with the Hong Kong Stock Exchange dated 18 June 2026.